GC
Gibson Christopher Chairman & CEO
C-suite M
US US · SEC (Form 4)
Browse the complete record of transactions filed by Gibson Christopher, Chairman & CEO. Director active across 1 companies, notably Recursion Pharmaceuticals, INC.. Cumulatively, 28 reports have been published. The latest transaction was disclosed on 2 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations 28 total
€72,086 31,250 shares @ €2.3067 0.0033% mcap 6.5% of flow
Class A Common Stock
SEC:0001209191-22-034743:0 · 2 Jun 2022
€31,308 5,764 shares @ €5.4316 0.0014% mcap 2.8% of flow
Class A Common Stock
SEC:0001209191-22-030244:0 · 16 May 2022
€72,958 31,250 shares @ €2.3347 0.0034% mcap 6.6% of flow
Class A Common Stock
SEC:0001209191-22-027702:0 · 4 May 2022
€103,906 44,010 shares @ €2.361 0.0048% mcap 9.4% of flow
Class A Common Stock
SEC:0001209191-22-026558:0 · 28 Apr 2022
€100,732 44,010 shares @ €2.2888 0.0047% mcap 9.1% of flow
Class A Common Stock
SEC:0001209191-22-025580:0 · 21 Apr 2022
€101,231 44,010 shares @ €2.3002 0.0047% mcap 9.1% of flow
Class A Common Stock
SEC:0001209191-22-025124:0 · 18 Apr 2022
€100,864 44,010 shares @ €2.2918 0.0047% mcap 9.1% of flow
Class A Common Stock
SEC:0001209191-22-024679:0 · 14 Apr 2022
€100,457 44,010 shares @ €2.2826 0.0047% mcap 9.1% of flow
Class A Common Stock
SEC:0001209191-22-024223:0 · 8 Apr 2022
€100,457 44,010 shares @ €2.2826 0.0047% mcap 9.1% of flow
Class A Common Stock
SEC:0001209191-22-024067:0 · 7 Apr 2022
€100,149 44,010 shares @ €2.2756 0.0046% mcap 9.0% of flow
Class A Common Stock
SEC:0001209191-22-023903:0 · 6 Apr 2022
€100,074 44,010 shares @ €2.2739 0.0046% mcap 9.0% of flow
Class A Common Stock
SEC:0001209191-22-023760:0 · 5 Apr 2022
0100,000 shares 0
Class A Common Stock
SEC:0001209191-22-019019:0 · 11 Mar 2022
0300,000 shares 0
Class A Common Stock
SEC:0001209191-22-017736:0 · 7 Mar 2022
0100,000 shares 0
Class A Common Stock
SEC:0001209191-22-012844:0 · 22 Feb 2022
0208,175 shares 0
Class A Common Stock
SEC:0001209191-22-007909 · 4 Feb 2022
0208,175 shares 0
Class A Common Stock
SEC:0001209191-22-007909:0 · 4 Feb 2022
019,858 shares 0
Class A Common Stock
SEC:0001209191-22-006596 · 31 Jan 2022
019,858 shares 0
Class A Common Stock
SEC:0001209191-22-006596:0 · 31 Jan 2022
087,000 shares 0
Class A Common Stock
SEC:0001209191-22-003402 · 13 Jan 2022
087,000 shares 0
Class A Common Stock
SEC:0001209191-22-003402:0 · 13 Jan 2022
0200 shares 0
Class A Common Stock
SEC:0001209191-21-070627 · 16 Dec 2021
0200 shares 0
Class A Common Stock
SEC:0001209191-21-070627:0 · 16 Dec 2021
0100 shares 0
Class A Common Stock
SEC:0001209191-21-069853 · 13 Dec 2021
0100 shares 0
Class A Common Stock
SEC:0001209191-21-069853:0 · 13 Dec 2021
€62,746 28,646 shares @ €2.1904 100.0% of flow
Class A Common Stock
SEC:0001209191-21-069159 · 8 Dec 2021
25 of 28 declarations
Load more (3 remaining) About Gibson Christopher Christopher Gibson is an executive at RECURSION PHARMACEUTICALS, INC.